Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acutus Medical's gross profit for the
three
months ended in Dec. 2024 was $1.01 Mil. Acutus Medical's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $1.00 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Acutus Medical's gross profit for the
three
months ended in Dec. 2024 was $1.01 Mil. Acutus Medical's Revenue for the
three
months ended in Dec. 2024 was $7.13 Mil. Therefore, Acutus Medical's Gross Margin % for the quarter that ended in Dec. 2024 was 14.10%.
Acutus Medical had a gross margin of 14.10% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
Acutus Medical (OTCPK:AFIB) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Acutus Medical had a gross margin of 14.10% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
Acutus Medical Gross Profit Related Terms
Acutus Medical Gross Profit Historical Data
* Premium members only.
The historical data trend for Acutus Medical's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Acutus Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acutus Medical Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acutus Medical's Gross Profit distribution charts can be found below:
* The bar in red indicates where Acutus Medical's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.00 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Acutus Medical (AFIB) has a Gross Profit of $1.00 Mil as of Dec. 2024. Gross Profit equals net sales less total cost of goods sold. View historical data on Acutus Medical and its competitors.
Is Acutus Medical's Gross Profit too high?
Acutus Medical's current Gross Profit is $1.00 Mil.
How does Acutus Medical's Gross Profit compare to DHAI and ABT?
Acutus Medical's Gross Profit of $1.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Acutus Medical and its competitors. Acutus Medical's current Gross Profit is $1.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acutus Medical stock overvalued right now?
Acutus Medical (AFIB) has a current Gross Profit of $1.00 Mil. The current Gross Profit is $1.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Acutus Medical (AFIB), the current Gross Profit is $1.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping, and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products world-wide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AFIB has been successfully added to your 
